Company
CDT Equity Inc. (CDT)
Standardized SEC financial data for CDT Equity Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001896212 · NASDAQ · Pharmaceutical Preparations.
Return on equity
547.1%
Free cash flow
-$15.6M
Current ratio
0.34×
EPS (diluted)
$-1177.89
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| R&D expense | $37K | $90K | $3.4M | $5.1M |
| SG&A expense | $3.0M | $5.2M | $12.0M | $31.7M |
Balance sheet
| USD | FY2023 | FY2023 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | $4.2M | $600K | $1.5M |
| Total current assets |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$2.3M | -$7.7M | -$9.7M | -$15.6M |
| Capital expenditures | — | — | $51K | — |
Get CDT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CDT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CDT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"